Vice President, Global Program Team Leader

Description

Reporting to the SVP, Product Strategy & Commercialization, the Vice President, Global Program Team Leader (PTL) will be responsible for leading the cross-functional strategy team for one or more development candidates. This cross-functional leader should be able to effectively communicate across a broad range of audiences, including the Executive team and the Board of Directors, and have an ability to clearly articulate program-specific strategies across Clinical Development, Technical Operations, Regulatory, and Commercial. The ideal candidate will provide strategic acumen and exemplary leadership skills to guide the team to shape program strategy and drive optimal decisions as we endeavor to bring new therapies to patients.

The role is based in San Carlos, CA.

WHAT YOU'LL DO AT CARGO THERAPEUTICS

• Lead one or more Program team comprised of functional representatives from Research, Regulatory, Technical Operations, Clinical Development, and Commercial from preclinical candidate selection through approval and launch
• Partner with stakeholders to set clear direction and goals for a portfolio of pre-clinical and clinical stage therapies, ensuring the development and execution of program strategy is in line with corporate strategy and goals
• Oversee and drive the development and communication of the Integrated Program Plan and the Program Development Plan in partnership with the Program team and Global Program Manager
• Facilitate cross-functional communication; drive strategic and operational alignment with the Program team, functional leads, and Executive team
• Identify challenges and risks and prepare the team with mitigations to navigate through technical and program challenges as they arise
• Promote curiosity, scientific rigor, and excellent problem-solving skills across a fast-paced, performance-driven environment
• Serve as the single point of accountability for the Program team, and drive key program decisions through appropriate governance forums, where appropriate

THE RIGHT STUFF: Required Experience & Qualifications

• An advanced degree in life sciences or medicine and/or an MBA
• Demonstrated cross-functional leadership experience, and an innate ability to collaborate with Program teams
• 15+ years of relevant experience working directly in the Pharmaceutical/Biotechnology industry, with 5+ years of experience leading cross-functional development teams
• Demonstrated in-depth knowledge of drug development, from preclinical to late-stage development, including experience submitting BLAs and MAAs to the FDA and EMA
• Able to comfortably dive into any area of the program, understand science, technical, and business needs, and make decisions based on changing priorities
• Excellent interpersonal, communication, and presentation skills in order to represent the program to key internal and external stakeholders
• Experience in cell therapy and/or lymphoma therapeutic area development is preferred
• Proven leadership and demonstrated ability to engage and influence team members at all levels in a matrixed environment
• Demonstrated success in influencing colleagues and senior leaders in various departments
• Ability to cultivate excellent cross-functional collaborations
• Proven effectiveness developing and growing productive relationships with stakeholders in a range of disciplines
• An inclusive individual who thrives in a team-oriented environment
• High energy and driven to deliver on program success

PAY RANGE

The combined pay range for this role is $260,000 - $360,000. Title and salary will be based on our assessment of skills and experience relevant to our needs for the role.

ABOUT CARGO THERAPEUTICS

CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. CARGO's programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved cell therapies, including limited durability of effect, safety concerns and unreliable supply. CARGO is currently evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy. CARGO also plans to evaluate CRG-022 in patients at earlier stages of disease, including LBCL and other hematologic malignancies. Beyond its lead program, CARGO is leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic "cargo" designed to enhance CAR T-cell persistence and trafficking to tumor lesions, as well as to help safeguard against tumor resistance and T-cell exhaustion. CARGO's founders are pioneers and world-class experts in CAR T-cell therapy, and its team has significant experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. For more information, please visit the CARGO Therapeutics website at https://cargo-tx.com/.

Join us to help make a difference!

EEO & EMPLOYMENT ELIGIBILITY

CARGO Therapeutics, Inc. is committed to building a diverse, equitable, and inclusive company. We provide equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability, or veteran status. CARGO Therapeutics, Inc. also complies with all applicable national, state, and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification required of applicable law.

CARGO Therapeutics requires all new hires to be fully vaccinated against COVID-19 as of their start date. This requirement is a condition of employment at CARGO Therapeutics, and it applies regardless of whether the position is located at a CARGO Therapeutics site or is fully remote. If you are unable to receive the vaccine due to a disability or serious medical condition, or because it is prohibited because of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation.